IDPH Welcomes CDC Recommendations For RSV Shots For Pregnant Illinoisans, Infants & Seniors
 CHICAGO – The Illinois Department of Public Health (IDPH) today endorsed the recommendation by the CDC’s Advisory Committee on Immunization Practices (ACIP) for the newly FDA-approved vaccine for RSV that can be administered during weeks 32 to 36 of pregnancy to protect babies from the virus. This followed recommendations earlier this year for a preventive RSV treatment for infants up to 8 months and toddlers at high risk, and an RSV vaccine for people over 60. IDPH urges those who are pregnant to consult with their doctor about whether they should receive the vaccine while pregnant or instead provide the preventive treatment for their newborn after birth. If the vaccine is received during pregnancy, infants will be protected and not need the preventive treatment after birth. As fall begins, IDPH is closely monitoring data on COVID-19 as well as other respiratory viruses including flu and RSV. The latest data shows that new hospitalizations for COVID-19 remain at a low
 stLouIST
stLouIST